-
Symbol
-
SAGE on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share (the "Common Stock")
-
Latest Disclosed Ownership
-
6.24M shares
-
Security Ownership
-
10.2%
BIOGEN INC. ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
2025-01-10 - BIOGEN INC. has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.24M shares of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE).
This represents 10.2% percent ownership of the company.